Cell-specific expression of calcineurin immunoreactivity within the rat basolateral amygdala complex and colocalization with the neuropeptide Y Y1 receptor

Journal of Chemical Neuroanatomy

Volumn 45, Issue 1-2, 2012, Pages 50-56

  Leitermann, Randy J ^a   Sajdyk, Tammy J ^b   Urban, Janice H ^a  

^a ROSALIND FRANKLIN UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

^b INDIANA UNIVERSITY   (United States)

Author keywords

Basolateral amygdaloid complex (BLA); Calcineurin (CaN); Calcium calmodulin kinase II (CaMKII); GABA; Neuropeptide Y (NPY); Neuropeptide Y Y1 receptor (Y1r)

Indexed keywords

4 AMINOBUTYRIC ACID; CALCINEURIN; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE II; NEUROPEPTIDE Y; NEUROPEPTIDE Y1 RECEPTOR;

AMYGDALOID NUCLEUS; ANIMAL BEHAVIOR; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANXIETY; ARTICLE; BASOLATERAL AMYGDALOID COMPLEX; BRAIN; CELL SPECIFICITY; CELL TYPE; CONFOCAL MICROSCOPY; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; NERVE CELL PLASTICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RAT;

AMYGDALA; ANIMALS; CALCINEURIN; IMMUNOHISTOCHEMISTRY; NEURONS; RATS; RATS, SPRAGUE-DAWLEY; RATS, WISTAR; RECEPTORS, NEUROPEPTIDE Y; SIGNAL TRANSDUCTION;

EID: 84866488507     PISSN: 08910618     EISSN: 18736300     Source Type: Journal    
DOI: 10.1016/j.jchemneu.2012.07.005     Document Type: Article

References (73)

1. Aakerlund L., Gether U., Fuhlendorff J., Schwartz T.W., Thastrup O. Y1 receptors for neuropeptide Y are coupled to mobilization of intracellular calcium and inhibition of adenylate cyclase. FEBS Letters 1990, 260:73-78.
2. Adrian T.E., Allen J.M., Bloom S.R., Ghatei M.A., Rossor M.N., Roberts G.W., Crow T.J., Tatemoto K., Polak J.M. Neuropeptide Y distribution in human brain. Nature 1983, 306:584-586.
3. Alagarsamy S., Gereau R.W., Mansuy L., Warren P.J. NMDA-induced reversal of mGluR5 desensitization is mediated by activation of protein phosphatase 2B/calcineurin. Society for Neuroscience Abstract 2002.
4. Allen Y.S., Adrian T.E., Allen J.M., Tatemoto K., Crow T.J., Bloom S.R., Polak J.M. Neuropeptide Y distribution in the rat brain. Science 1983, 221:877-879.
5. Bahi A., Mineur Y.S., Picciotto M.R. Blockade of protein phosphatase 2B activity in the amygdala increases anxiety- and depression-like behaviors in mice. Biological Psychiatry 2009, 66:1139-1146.
6. Bannon A.W., Seda J., Carmouche M., Francis J.M., Norman M.H., Karbon B., McCaleb M.L. Behavioral characterization of neuropeptide Y knockout mice. Brain Research 2000, 868:79-87.
7. Baumgartel K., Genoux D., Welzl H., Tweedie-Cullen R.Y., Koshibu K., Livingstone-Zatchej M., Mamie C., Mansuy I.M. Control of the establishment of aversive memory by calcineurin and Zif268. Nature Neuroscience 2008, 11:572-578.
8. Beattie E.C., Carroll R.C., Yu X., Morishita W., Yasuda H., von Zastrow M., Malenka R.C. Regulation of AMPA receptor endocytosis by a signaling mechanism shared with LTD. Nature Neuroscience 2000, 3:1291-1300.
9. (2+)- and stimulus duration-dependent switch for hippocampal gene expression. Cell 1996, 87:1203-1214.
10. Cannich A., Wotjak C.T., Kamprath K., Hermann H., Lutz B., Marsicano G. CB1 cannabinoid receptors modulate kinase and phosphatase activity during extinction of conditioned fear in mice. Learning and Memory 2004, 11:625-632.
11. Chang K.T., Berg D.K. Voltage-gated channels block nicotinic regulation of CREB phosphorylation and gene expression in neurons. Neuron 2001, 32:855-865.
12. de Quidt M.E., Emson P.C. Distribution of neuropeptide Y-like immunoreactivity in the rat central nervous system. II. Immunohistochemical analysis. Neuroscience 1986, 18:545-618.
13. Dumont Y., Martel J.C., Fournier A., St Pierre S., Quirion R. Neuropeptide Y and neuropeptide Y receptor subtypes in brain and peripheral tissues. Progress in Neurobiology 1992, 38:125-167.
14. Erickson J.C., Clegg K.E., Palmiter R.D. Sensitivity to leptin and susceptibility to seizures of mice lacking neuropeptide Y. Nature 1996, 381:415-421.
15. 2+/calmodulin-dependent protein kinase in rat brain. Journal of Neuroscience 1985, 5:3270-3277.
16. Giesbrecht C.J., Mackay J.P., Silveira H.B., Urban J.H., Colmers W.F. Countervailing modulation of Ih by neuropeptide Y and corticotrophin-releasing factor in basolateral amygdala as a possible mechanism for their effects on stress-related behaviors. Journal of Neuroscience 2010, 30:16970-16982.
17. Gjerris A., Widerlov E., Werdelin L., Ekman R. Cerebrospinal fluid concentrations of neuropeptide Y in depressed patients and in controls. Journal of Psychiatry and Neuroscience 1992, 17:23-27.
18. Heilig M. The NPY system in stress, anxiety and depression. Neuropeptides 2004, 38:213-224.
19. Helmstetter F.J. Stress-induced hypoalgesia and defensive freezing are attenuated by application of diazepam to the amygdala. Pharmacology Biochemistry and Behavior 1993, 44:433-438.
20. 2+ sparks in adult rat ventricular myocytes through Y1 receptor and PLC activation. Journal of Molecular and Cellular Cardiology 2005, 38:205-212.
21. Isoardi N.A., Bertotto M.E., Martijena I.D., Molina V.A., Carrer H.F. Lack of feedback inhibition on rat basolateral amygdala following stress or withdrawal from sedative-hypnotic drugs. European Journal of Neuroscience 2007, 26:1036-1044.
22. Jones M.V., Westbrook G.L. Shaping of IPSCs by endogenous calcineurin activity. Journal of Neuroscience 1997, 17:7626-7633.
23. Jung S., Bullis J.B., Lau I.H., Jones T.D., Warner L.N., Poolos N.P. Downregulation of dendritic HCN channel gating in epilepsy is mediated by altered phosphorylation signaling. Journal of Neuroscience 2010, 30:6678-6688.
24. Klee C.B., Draetta G.F., Hubbard M.J. Calcineurin. Advances in Enzymology and Related Areas of Molecular Biology 1988, 61:149-200.
25. Kurz J.E., Moore B.J., Henderson S.C., Campbell J.N., Churn S.B. A cellular mechanism for dendritic spine loss in the pilocarpine model of status epilepticus. Epilepsia 2008, 49:1696-1710.
26. (2+)-dependent phosphatase. Nature 1994, 369:235-239.
27. Lin C.H., Lee C.C., Gean P.W. Involvement of a calcineurin cascade in amygdala depotentiation and quenching of fear memory. Molecular Pharmacology 2003, 63:44-52.
28. Lin C.H., Yeh S.H., Leu T.H., Chang W.C., Wang S.T., Gean P.W. Identification of calcineurin as a key signal in the extinction of fear memory. Journal of Neuroscience 2003, 23:1574-1579.
29. Lin J.W., Ju W., Foster K., Lee S.H., Ahmadian G., Wyszynski M., Wang Y.T., Sheng M. Distinct molecular mechanisms and divergent endocytotic pathways of AMPA receptor internalization. Nature Neuroscience 2000, 3:1282-1290.
30. Malleret G., Haditsch U., Genoux D., Jones M.W., Bliss T.V., Vanhoose A.M., Weitlauf C., Kandel E.R., Winder D.G., Mansuy I.M. Inducible and reversible enhancement of learning, memory, and long-term potentiation by genetic inhibition of calcineurin. Cell 2001, 104:675-686.
31. Maren S., Aharonov G., Stote D.L., Fanselow M.S. N-methyl-d-aspartate receptors in the basolateral amygdala are required for both acquisition and expression of conditional fear in rats. Behavioral Neuroscience 1996, 110:1365-1374.
32. McDonald A.J. Neurons of the lateral and basolateral amygdaloid nuclei: a Golgi study in the rat. Journal of Comparative Neurology 1982, 212:293-312.
33. McDonald A.J., Muller J.F., Mascagni F. GABAergic innervation of alpha type II calcium/calmodulin-dependent protein kinase immunoreactive pyramidal neurons in the rat basolateral amygdala. Journal of Comparative Neurology 2002, 446:199-218.
34. McDonald A.J., Pearson J.C. Coexistence of GABA and peptide immunoreactivity in non-pyramidal neurons of the basolateral amygdala. Neuroscience Letters 1989, 100:53-58.
35. Mesches M.H., Bianchin M., McGaugh J.L. The effects of intra-amygdala infusion of the AMPA receptor antagonist CNQX on retention performance following aversive training. Neurobiology of Learning and Memory 1996, 66:324-340.
36. Morgan C.A., Wang S., Southwick S.M., Rasmusson A., Hazlett G., Hauger R.L., Charney D.S. Plasma neuropeptide-Y concentrations in humans exposed to military survival training. Biological Psychiatry 2000, 47:902-909.
37. 2+ and inhibits adenylate cyclase in human erythroleukemia cells. American Journal of Physiology 1988, 255:E880-E885.
38. Mulkey R.M., Endo S., Shenolikar S., Malenka R.C. Involvement of a calcineurin/inhibitor-1 phosphatase cascade in hippocampal long-term depression. Nature 1994, 369:486-488.
39. Nikisch G., Agren H., Eap C.B., Czernik A., Baumann P., Mathe A.A. Neuropeptide Y and corticotropin-releasing hormone in CSF mark response to antidepressive treatment with citalopram. International Journal of Neuropsychopharmacology 2005, 8:403-410.
40. Nikisch G., Mathe A.A. CSF monoamine metabolites and neuropeptides in depressed patients before and after electroconvulsive therapy. European Psychiatry 2008, 23:356-359.
41. (2+) channel activity in hippocampal neurons: increased effect with age in culture. Neuroscience 2002, 110:213-225.
42. Pandey S.C., Roy A., Mittal N. Effects of chronic ethanol intake and its withdrawal on the expression and phosphorylation of the creb gene transcription factor in rat cortex. Journal of Pharmacology and Experimental Therapeutics 2001, 296:857-868.
43. Pape H.C., Pare D. Plastic synaptic networks of the amygdala for the acquisition, expression, and extinction of conditioned fear. Physiological Reviews 2010, 90:419-463.
44. Pare D., Collins D.R. Neuronal correlates of fear in the lateral amygdala: multiple extracellular recordings in conscious cats. Journal of Neuroscience 2000, 20:2701-2710.
45. Perney T.M., Miller R.J. Two different G-proteins mediate neuropeptide Y and bradykinin-stimulated phospholipid breakdown in cultured rat sensory neurons. Journal of Biological Chemistry 1989, 264:7317-7327.
46. Primeaux S.D., Wilson S.P., Cusick M.C., York D.A., Wilson M.A. Effects of altered amygdalar neuropeptide Y expression on anxiety-related behaviors. Neuropsychopharmacology 2005, 30:1589-1597.
47. Rainnie D.G., Bergeron R., Sajdyk T.J., Patil M., Gehlert D.R., Shekhar A. Corticotrophin releasing factor-induced synaptic plasticity in the amygdala translates stress into emotional disorders. Journal of Neuroscience 2004, 24:3471-3479.
48. Rodriguez Manzanares P.A., Isoardi N.A., Carrer H.F., Molina V.A. Previous stress facilitates fear memory, attenuates GABAergic inhibition, and increases synaptic plasticity in the rat basolateral amygdala. Journal of Neuroscience 2005, 25:8725-8734.
49. Roozendaal B., McEwen B.S., Chattarji S. Stress, memory and the amygdala. Nature Reviews Neuroscience 2009, 10:423-433.
50. Rostkowski A.B., Teppen T.L., Peterson D.A., Urban J.H. Cell-specific expression of neuropeptide Y Y1 receptor immunoreactivity in the rat basolateral amygdala. Journal of Comparative Neurology 2009, 517:166-176.
51. Sah R., Ekhator N.N., Strawn J.R., Sallee F.R., Baker D.G., Horn P.S., Geracioti T.D. Low cerebrospinal fluid neuropeptide Y concentrations in posttraumatic stress disorder. Biological Psychiatry 2009, 66:705-707.
52. Sajdyk T.J., Johnson P.L., Leitermann R.J., Fitz S.D., Dietrich A., Morin M., Gehlert D.R., Urban J.H., Shekhar A. Neuropeptide Y in the amygdala induces long-term resilience to stress-induced reductions in social responses but not hypothalamic-adrenal-pituitary axis activity or hyperthermia. Journal of Neuroscience 2008, 28:893-903.
53. Sajdyk T.J., Schober D.A., Gehlert D.R. Neuropeptide Y receptor subtypes in the basolateral nucleus of the amygdala modulate anxiogenic responses in rats. Neuropharmacology 2002, 43:1165-1172.
54. Sajdyk T.J., Schober D.A., Smiley D.L., Gehlert D.R. Neuropeptide Y-Y2 receptors mediate anxiety in the amygdala. Pharmacology Biochemistry and Behavior 2002, 71:419-423.
55. Sajdyk T.J., Shekhar A. Excitatory amino acid receptor antagonists block the cardiovascular and anxiety responses elicited by gamma-aminobutyric acid A receptor blockade in the basolateral amygdala of rats. Journal of Pharmacology and Experimental Therapeutics 1997, 283:969-977.
56. Sajdyk T.J., Vandergriff M.G., Gehlert D.R. Amygdalar neuropeptide Y Y1 receptors mediate the anxiolytic-like actions of neuropeptide Y in the social interaction test. European Journal of Pharmacology 1999, 368:143-147.
57. Scheel-Kruger J., Petersen E.N. Anticonflict effect of the benzodiazepines mediated by a GABAergic mechanism in the amygdala. European Journal of Pharmacology 1982, 82:115-116.
58. Sheriff S., Qureshy F., Chance T., Kasckow J.W., Balasubramaniam A. Predominant role by CaM kinase in NPY Y(1) receptor signaling: involvement of CREB. Peptides 2002, 23:87-96.
59. Shigeri Y., Fujimoto M. Two different signal transductions of neuropeptide Y1 receptor in SK-N-MC cells. Biochemical and Biophysical Research Communications 1992, 187:1565-1571.
60. Sosulina L., Schwesig G., Seifert G., Pape H.C. Neuropeptide Y activates a G-protein-coupled inwardly rectifying potassium current and dampens excitability in the lateral amygdala. Molecular and Cellular Neurosciences 2008, 39:491-498.
61. Stanic D., Mulder J., Watanabe M., Hokfelt T. Characterization of NPY Y2 receptor protein expression in the mouse brain. II. Coexistence with NPY, the Y1 receptor, and other neurotransmitter-related molecules. Journal of Comparative Neurology 2011, 519:1219-1257.
62. Szabat E., Soinila S., Happola O., Linnala A., Virtanen I. A new monoclonal antibody against the GABA-protein conjugate shows immunoreactivity in sensory neurons of the rat. Neuroscience 1992, 47:409-420.
63. Tasan R.O., Nguyen N.K., Weger S., Sartori S.B., Singewald N., Heilbronn R., Herzog H., Sperk G. The central and basolateral amygdala are critical sites of neuropeptide Y/Y2 receptor-mediated regulation of anxiety and depression. Journal of Neuroscience 2010, 30:6282-6290.
64. Tong G., Shepherd D., Jahr C.E. Synaptic desensitization of NMDA receptors by calcineurin. Science 1995, 267:1510-1512.
65. Urban J.H., Leitermann R.J., DeJoseph M.R., Somponpun S.J., Wolak M.L., Sladek C.D. Influence of dehydration on the expression of neuropeptide Y Y1 receptors in hypothalamic magnocellular neurons. Endocrinology 2006, 147:4122-4131.
66. Wahlestedt C., Yanaihara N., Hakanson R. Evidence for different pre- and post-junctional receptors for neuropeptide Y and related peptides. Regulatory Peptides 1986, 13:307-318.
67. Wang J., Liu S., Haditsch U., Tu W., Cochrane K., Ahmadian G., Tran L., Paw J., Wang Y., Mansuy I., Salter M.M., Lu Y.M. Interaction of calcineurin and type-A GABA receptor gamma 2 subunits produces long-term depression at CA1 inhibitory synapses. Journal of Neuroscience 2003, 23:826-836.
68. Widerlov E., Lindstrom L.H., Wahlestedt C., Ekman R. Neuropeptide Y and peptide YY as possible cerebrospinal fluid markers for major depression and schizophrenia, respectively. Journal of Psychiatric Research 1988, 22:69-79.
69. Wolak M.L., DeJoseph M.R., Cator A.D., Mokashi A.S., Brownfield M.S., Urban J.H. Comparative distribution of neuropeptide Y Y1 and Y5 receptors in the rat brain by using immunohistochemistry. Journal of Comparative Neurology 2003, 464:285-311.
70. Yehuda R., Brand S., Yang R.K. Plasma neuropeptide Y concentrations in combat exposed veterans: relationship to trauma exposure, recovery from PTSD, and coping. Biological Psychiatry 2006, 59:660-663.
71. Zeng H., Chattarji S., Barbarosie M., Rondi-Reig L., Philpot B.D., Miyakawa T., Bear M.F., Tonegawa S. Forebrain-specific calcineurin knockout selectively impairs bidirectional synaptic plasticity and working/episodic-like memory. Cell 2001, 107:617-629.
72. Zhou Q., Homma K.J., Poo M.M. Shrinkage of dendritic spines associated with long-term depression of hippocampal synapses. Neuron 2004, 44:749-757.
73. Zhou Z., Zhu G., Hariri A.R., Enoch M.A., Scott D., Sinha R., Virkkunen M., Mash D.C., Lipsky R.H., Hu X.Z., Hodgkinson C.A., Xu K., Buzas B., Yuan Q., Shen P.H., Ferrell R.E., Manuck S.B., Brown S.M., Hauger R.L., Stohler C.S., Zubieta J.K., Goldman D. Genetic variation in human NPY expression affects stress response and emotion. Nature 2008, 452:997-1001.